Albumin and hemoglobin levels, as well as lymphocyte and platelet counts, are common clinical biomarkers that constitute the HALP score, first introduced in 2015 by Chen et al. for predicting survival outcomes in patients with gastric cancer (8). The gene discussed is ALB; the disease is gastric cancer.